imatinib mesylate has been researched along with Granulomas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cingolani, F; Cleverley, TL; Garcia, PK; Guarner, J; Kalman, D; Koehler, H; Mocarski, ES; Peddineni, S | 1 |
| Provost, N; Vadeboncoeur, S | 1 |
| Fujiwara, M; Goto, H; Goya, T; Ishii, H; Koide, T; Nakajima, A; Nakamoto, K; Oka, T; Saraya, T; Shibata, H | 1 |
1 review(s) available for imatinib mesylate and Granulomas
| Article | Year |
|---|---|
[A case of imatinib mesylate-induced pneumonitis based on the detection of epithelioid granulomas by video-assisted thoracoscopic surgery biopsy in a patient with chronic myeloid leukemia].
Topics: Aged; Antineoplastic Agents; Benzamides; Biopsy; Granuloma; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pneumonia; Pyrimidines; Thoracic Surgery, Video-Assisted | 2011 |
2 other study(ies) available for imatinib mesylate and Granulomas
| Article | Year |
|---|---|
The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Granuloma; Humans; Imatinib Mesylate; Mice; Piperazines; Pyrimidines | 2023 |
Multiple Xanthogranulomas in an Adult: Known Entity, New Association.
Topics: Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Eruptions; Female; Gastrointestinal Stromal Tumors; Granuloma; Histiocytosis, Non-Langerhans-Cell; Humans; Imatinib Mesylate; Stomach Neoplasms; Xanthomatosis | 2016 |